Hair Diseases Epidemiology Forecast 2025-2034

Studies show that the most common hair and scalp disorders include androgenetic alopecia (30.6%), alopecia areata (19.3%), telogen effluvium (15.4%), nonscarring folliculitis (15.4%), seborrheic dermatitis (14.9%), lichen planopilaris (7.1%), and folliculitis decalvans (6.6%). It is also reported that the cases of androgenetic alopecia (AGA) and frontal fibrosing alopecia (FFA) have significantly increased over time.

Hair Diseases Epidemiology Forecast Report Coverage

The “Hair Diseases Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of hair diseases. It projects the future incidence and prevalence rates of hair diseases across various populations. The study covers age, gender, and type as major determinants of the hair diseases-affected population. The report highlights patterns in the prevalence of hair diseases over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of hair diseases in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Hair Diseases Overview

Hair diseases include a group of conditions that affect the hair and scalp, causing hair loss (alopecia), abnormalities in hair structure, scalp inflammation, or infections. These disorders are known to significantly impact the physical appearance and emotional well-being of the affected individual. Androgenetic alopecia, commonly called pattern hair loss, is the most prevalent hair disorder and affects both men and women. Genetic factors and hormonal imbalances (such as those during pregnancy, menopause, or thyroid dysfunction) can also influence hair growth.

Hair Diseases: Treatment Overview

The treatment of hair diseases usually depends on the type of condition, severity, and patient's profile. It includes a combination of medical therapies, non-invasive procedures, and lifestyle changes. Common topical medications like minoxidil help stimulate hair growth and slow hair loss in androgenetic alopecia. Corticosteroids, in the form of creams, foams, or scalp injections, are also prescribed to reduce inflammation and suppress the immune response in conditions like alopecia areata or lichen planopilaris.

Epidemiology

The hair diseases epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for hair diseases by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for hair diseases and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• As per a research article published in the Journal of the European Academy of Dermatology and Venereology, the most common hair and scalp disorders include androgenetic alopecia (30.6%), alopecia areata (19.3%), telogen effluvium (15.4%), nonscarring folliculitis (15.4%), seborrheic dermatitis (14.9%), lichen planopilaris (7.1%), and folliculitis decalvans (6.6%).
• About 1 in 50 people experience alopecia areata at some point in their lives. It affects men and women of all races equally and usually begins before age 30.
• Studies show that androgenetic alopecia is observed to affect nearly 50% of men and women of African or European heritage. However, it is reported to be less prevalent among Asians.
• Hirsutism affects 4% to 11% of women in the general population, but it is a primary symptom of hyperandrogenism in women with polycystic ovary syndrome and occurs in 65% to 75% of cases.

Country-wise Hair Diseases Epidemiology

The hair diseases epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of hair diseases varies between countries owing to differences in factors such as genetic predisposition, environmental conditions, dietary patterns, healthcare access, and socioeconomic status. In the United States, around 50 million men and 30 million women are affected by androgenetic alopecia, with the risk increasing with age.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of hair diseases based on several factors.
• Hair Diseases Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of hair diseases are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of hair diseases epidemiology in the 8 major markets?
• What will be the total number of patients with hair diseases across the 8 major markets during the forecast period?
• What was the country-wise prevalence of hair diseases in the 8 major markets in the historical period?
• Which country will have the highest number of hair diseases patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of hair diseases during the forecast period of 2025-2034?
• What are the currently available treatments for hair diseases?
• What are the disease risks, signs, symptoms, and unmet needs of hair diseases?

This product will be delivered within 3-5 business days.